veratridine has been researched along with am 251 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| David, LS; Liao, C; Nicholson, RA; Zheng, J | 1 |
| Duan, Y; Jain, S; Liao, C; Nicholson, RA | 1 |
2 other study(ies) available for veratridine and am 251
| Article | Year |
|---|---|
Inhibition of voltage-sensitive sodium channels by the cannabinoid 1 receptor antagonist AM 251 in mammalian brain.
Topics: Animals; Batrachotoxins; Brain; Cannabinoid Receptor Antagonists; Drug Interactions; Male; Membrane Potentials; Mice; Piperidines; Pyrazoles; Sodium Channels; Synaptosomes; Veratridine | 2004 |
The cannabinoid receptor agonist CP-55,940 and ethyl arachidonate interfere with [(3)H]batrachotoxinin A 20 alpha-benzoate binding to sodium channels and inhibit sodium channel function.
Topics: Animals; Arachidonic Acids; Batrachotoxins; Brain; Cannabinoid Receptor Agonists; Cyclohexanols; Mice; Piperidines; Pyrazoles; Sodium Channels; Veratridine | 2008 |